Skip to site content

Coronavirus (COVID-19)

Coronavirus Disease 2019

The Indian Health Service continues to work closely with our tribal and urban Indian organization partners and state and local public health officials to coordinate a comprehensive public health response to the ongoing COVID-19 pandemic. The COVID-19 pandemic has disproportionately affected American Indian and Alaska Native populations across the country. American Indians and Alaska Natives have infection rates over 3.5 times higher Exit Disclaimer: You Are Leaving www.ihs.gov  than non-Hispanic whites, are over four times Exit Disclaimer: You Are Leaving www.ihs.gov  more likely to be hospitalized as a result of COVID-19, and have higher rates Exit Disclaimer: You Are Leaving www.ihs.gov  of mortality at younger ages than non-Hispanic whites. This has highlighted the need for comprehensive, culturally appropriate personal and public health services that are available and accessible to all American Indian and Alaska Native people.

A Historic Investment

The IHS has received a historic investment of more than $9 billion [PDF] to provide resources for IHS, tribal, and urban Indian health programs to address long-standing health inequities experienced by American Indians and Alaska Natives by ensuring a comprehensive public health response to the ongoing COVID-19 pandemic. We have worked closely with tribes and urban Indian organizations throughout this pandemic to get resources out to facilities as quickly as possible.

Increasing Availability and Access to Vaccination Sites

IHS continues to address barriers to COVID-19 vaccination in American Indian and Alaska Native communities by increasing availability to convenient and accessible vaccination sites; increasing clinical and community-based workforce for outreach, education, and vaccination; and accelerating COVID-19 vaccine distribution and administration. Across the Indian health system, we have administered well over one million vaccine doses, increased drive-through testing sites, and provided next-generation at home tests and rapid tests.

Achievements and Improvements

It has been more than a year now that IHS and our dedicated workforce have been responding to COVID-19. Over the past year, IHS has worked to ensure the safety of our IHS patients and staff, as well as tribal community members. We have made some considerable achievements such as developing a COVID-19 data surveillance system and partnering with the Navajo Nation and other local organizations on a project to support the installation of 59 transitional water points on the Navajo Nation. These efforts have increased water access for over 9,600 homes without piped water.

The pandemic has highlighted challenges and risks to our current health information technology system and has reinforced IHS’ commitment to the modernization of our health IT infrastructure. Despite these challenges, we have successfully expanded our use of technology to provide telehealth services during COVID-19.The funding for electronic health record modernization provided by Congress will allow us to proceed with the foundational steps in this important multi-year effort.

Importance of Partnerships

We look forward to continuing our work with tribal, urban Indian organization, and federal partners across the country. The IHS remains committed to working closely with our stakeholders and understands the importance of everyone coming together during this difficult time.

For the latest general information about COVID-19, we encourage everyone to periodically review CDC’s COVID-19 webpage Exit Disclaimer: You Are Leaving www.ihs.gov . Information on the number of COVID-19 vaccines administered across the IHS can be found on the CDC COVID Data Tracker Exit Disclaimer: You Are Leaving www.ihs.gov  in the Federal Entities section.

COVID-19 Vaccine Distribution and Administration by IHS Area

As of March 26, 2023, the IHS is distributing all COVID-19 vaccines currently authorized or approved in the U.S., including Pfizer-BioNTech, Moderna, and Novavax. Janssen/Johnson & Johnson may still be in stock and available for administration at IHS sites, but it is no longer available for order in the U.S. The table below shows the total number of vaccine doses distributed and administered to date, per IHS Area, for facilities that chose to receive vaccine through the IHS jurisdiction. The data includes COVID-19 vaccinations administered to all ages and specialty groups authorized for emergency use or fully licensed by the Food and Drug Administration (FDA).

Total Doses Distributed
Area Total Doses Distributed Total Doses Administered**
Albuquerque 287,530 202,736
Bemidji 335,330 186,859
Billings 197,170 89,467
California 498,850 236,205
Great Plains 394,480 186,479
Nashville 212,930 116,884
Navajo 678,700 431,507
Oklahoma City 880,295 533,551
Phoenix 472,875 269,107
Portland 220,230 114,822
Tucson 22,320 14,987
Grand Total 4,200,710 2,382,604

*Distributed Data Source: IHS National Supply Service Center, includes total doses ordered and delivered by March 24, 2023, to facilities that chose the IHS jurisdiction for vaccine distribution.

**Administered Data Source: Data is reported from the Vaccine Administration Management System (VAMS) and IHS Central Aggregator Service (CAS). Data may be different than data on the CDC COVID-19 Vaccine Tracker due to lags and ongoing quality review of data, including resolving data errors.

Note:The COVID-19 Vaccine Distribution and Administration by IHS Area data is only reflective of facilities that chose the IHS jurisdiction for vaccine distribution. Alaska Area data is not reported as all tribes chose to receive COVID-19 vaccine from the State of Alaska. The Tucson Area data only includes one tribe that chose the IHS jurisdiction for vaccine distribution.

COVID-19 Cases by IHS Area

Data are reported from IHS, tribal, and urban Indian organization facilities, though reporting by tribal and urban programs is voluntary. Data reflect cases reported to the IHS through 11:59 pm on Mar 29, 2023.

IHS Area
Tested
Positive
Negative
Cumulative
percent
positive
7-day rolling
average
positivity
Alaska 1,141,866 58,022 932,940 5.9% 15.9%
Albuquerque 186,778 17,515 143,395 10.9% 2.1%
Bemidji 334,809 35,250 297,982 10.6% 15.9%
Billings 163,705 14,497 144,272 9.1% 5.3%
California 211,696 23,939 177,087 11.9% 6.3%
Great Plains 324,156 35,146 283,541 11.0% 7.3%
Nashville 212,473 23,364 178,330 11.6% 8.0%
Navajo 632,358 93,016 461,233 16.8% 14.4%
Oklahoma 1,372,626 205,769 1,147,761 15.2% 9.3%
Phoenix 353,634 53,342 295,785 15.3% 7.6%
Portland 265,542 23,812 241,132 9.0% 9.1%
Tucson 88,519 10,102 78,163 11.4% 15.0%
TOTAL 5,288,162 593,774 4,381,621 11.9% 11.1%

COVID-19 testing data is updated on Thursdays.

IHS COVID-19 Dashboard

* Zoom in to see stats by IHS Area

Website last updated Mar 30, 2023